Masayuki Nagahashi
Overview
Explore the profile of Masayuki Nagahashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
3908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Natori K, Igeta M, Morimoto T, Nagahashi M, Akashi-Tanaka S, Daimon T, et al.
Breast Cancer
. 2025 Feb;
PMID: 39979692
Background: Immune and inflammatory blood parameters have been reported as biomarkers for treatment efficacy. This study aimed to establish a predictive model that includes blood parameters for patients with metastatic...
2.
Nagahashi M, Kumamaru H, Kinukawa N, Iwamoto T, Kawashima M, Kinoshita T, et al.
Breast Cancer
. 2025 Feb;
32(2):217-226.
PMID: 39910023
This is an annual report by the Japanese Breast Cancer Society, which provides statistics on the clinical data on breast cancer in Japan, extracted from the National Clinical Database-Breast Cancer...
3.
Oshiro A, Nagahashi M, Togashi Y, Kanaoka H, Hattori A, Tsuchida J, et al.
Anticancer Res
. 2025 Jan;
45(2):789-796.
PMID: 39890192
Background/aim: The Medical Imaging Projection System (MIPS) is a real-time projection mapping system with a highly sensitive fluorescence sensing system. The aim of this study was to investigate the clinical...
4.
Togashi Y, Nagahashi M, Kashima M, Okada C, Kinjo C, Miyazaki A, et al.
Surg Today
. 2025 Jan;
PMID: 39831988
Purpose: To clarify the status of multigene panel testing for suspected hereditary breast cancer in our institute, and disclose the characteristics of the variants detected. Methods: This was a retrospective...
5.
Nagahashi M, Ishikawa E, Nagai T, Kanaoka H, Oshiro A, Togashi Y, et al.
Breast Cancer
. 2025 Jan;
32(2):404-415.
PMID: 39808396
Purpose: The aim of this study was to examine the clinical utility of tumor-infiltrating lymphocytes (TILs) evaluated by "average" and "hot-spot" methods in breast cancer patients. Methods: We examined 367...
6.
Ishikawa E, Watanabe T, Kihara T, Kuroiwa M, Komatsu M, Urano S, et al.
Breast Cancer Res Treat
. 2024 Oct;
209(2):291-302.
PMID: 39402242
Purpose: Tumor-infiltrating lymphocyte (TIL) levels are prognostic and predictive factors for breast cancer. Unlike other subtypes, most luminal A breast cancers are immune deserts; however, the underlying mechanisms are poorly...
7.
Mitsuyoshi A, Nagahashi M, Kanaoka H, Oshiro A, Togashi Y, Hattori A, et al.
Int J Clin Oncol
. 2024 Sep;
29(12):1850-1859.
PMID: 39278979
Purpose: The aim of this study was to elucidate the clinical significance of peripheral blood biomarkers, including absolute lymphocyte count (ALC) and neutrophil-to-lymphocyte ratio (NLR), at the end of treatment...
8.
Nagahashi M, Miyoshi Y
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542328
In recent years, newly emerging therapies, such as immune checkpoint inhibitors and antibody-drug conjugates, have further improved outcomes for breast cancer patients. However, recurrent and metastatic breast cancer often eventually...
9.
Fukui R, Watanabe T, Morimoto K, Fujimoto Y, Nagahashi M, Ishikawa E, et al.
Breast Cancer
. 2024 Mar;
31(3):536-538.
PMID: 38433180
No abstract available.
10.
Iwamoto T, Kumamaru H, Niikura N, Sagara Y, Miyashita M, Konishi T, et al.
Breast Cancer
. 2024 Feb;
31(2):185-194.
PMID: 38319565
This is a prognostic report by the Japanese Breast Cancer Society on breast cancer extracted from the National Clinical Database-Breast Cancer Registry of Japan. Here, we present a summary of...